User menu

Identification and management of polyvascular disease in patients with noncardioembolic ischaemic stroke

Bibliographic reference Carolei, Antonio ; Chamorro, Angel ; Laloux, Patrice ; Leys, Didier ; Roether, Joachim ; et. al. Identification and management of polyvascular disease in patients with noncardioembolic ischaemic stroke. In: International Journal of Stroke, Vol. 3, no. 4, p. 237-248 (2008)
Permanent URL
  1. van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A, Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study, 10.1016/s0140-6736(05)66734-7
  2. Adams H. P., Bendixen B. H., Kappelle L. J., Biller J., Love B. B., Gordon D. L., Marsh E. E., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, 10.1161/01.str.24.1.35
  3. Kolominsky-Rabas P. L., Sarti C., Heuschmann P. U., Graf C., Siemonsen S., Neundoerfer B., Katalinic A., Lang E., Gassmann K.-G., von Stockert T. R., A Prospective Community-Based Study of Stroke in Germany The Erlangen Stroke Project (ESPro) : Incidence and Case Fatality at 1, 3, and 12 Months, 10.1161/01.str.29.12.2501
  4. Carolei A., Marini C., Di Napoli M., Di Gianfilippo G., Santalucia P., Baldassarre M., Giorgio De Matteis M., di Orio F., High Stroke Incidence in the Prospective Community-Based L'Aquila Registry (1994 1998) : First Year's Results, 10.1161/01.str.28.12.2500
  5. Sacco S, Riv Ital Neurobiologia, 2, 109 (2006)
  6. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, Redgrave JNE, Bull LM, Welch SJV, Cuthbertson FC, Binney LE, Gutnikov SA, Anslow P, Banning AP, Mant D, Mehta Z, Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study), 10.1016/s0140-6736(05)67702-1
  7. Marini C., Baldassarre M., Russo T., De Santis F., Sacco S., Ciancarelli I., Carolei A., Burden of first-ever ischemic stroke in the oldest old: Evidence from a population-based study, 10.1212/01.wnl.0000101461.61501.65
  8. Bhatt Deepak L., International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis, 10.1001/jama.295.2.180
  9. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), 10.1016/s0140-6736(96)09457-3
  10. Leys D., Woimant F., Ferrières J., Bauters C., Touboul P.-J., Guérillot M., Herrmann M.A., Priollet P., Detection and Management of Associated Atherothrombotic Locations in Patients with a Recent Atherothrombotic Ischemic Stroke: Results of the DETECT Survey, 10.1159/000090004
  11. Weimar C., Goertler M., Röther J., Ringelstein E. B., Darius H., Nabavi D. G., Kim I.-H., Theobald K., Diener H.-C., , Systemic Risk Score Evaluation in Ischemic Stroke Patients (SCALA) : A prospective cross sectional study in 85 German stroke units, 10.1007/s00415-007-0590-z
  12. Diehm C., Association of low ankle brachial index with high mortality in primary care, 10.1093/eurheartj/ehl092
  13. Toso V., Carolei A., Gensini G. F., Cimminiello C., Micieli G., Toni D., Zaninelli A., Bignamini A. A., , The Stroke in Italy and Related Impact on Outcome (SIRIO) study: design and baseline data, 10.1007/s10072-006-0633-8
  14. AGNELLI G., CIMMINIELLO C., MENEGHETTI G., URBINATI S., , Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events, 10.1111/j.1538-7836.2006.02225.x
  15. Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial, 10.1016/s0140-6736(96)91077-6
  16. Gongora-Rivera F., Labreuche J., Jaramillo A., Steg P. G., Hauw J.-J., Amarenco P., Autopsy Prevalence of Coronary Atherosclerosis in Patients With Fatal Stroke, 10.1161/01.str.0000260091.13729.96
  17. Tsai A. W., Folsom A. R., Rosamond W. D., Jones D. W., Ankle-Brachial Index and 7-Year Ischemic Stroke Incidence: The ARIC Study, 10.1161/01.str.32.8.1721
  18. Dhamoon M. S., Sciacca R. R., Rundek T., Sacco R. L., Elkind M.S.V., Recurrent stroke and cardiac risks after first ischemic stroke: The Northern Manhattan Study, 10.1212/01.wnl.0000201253.93811.f6
  19. Gomberg-Maitland Mardi, Frison Lars, Halperin Jonathan L, Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality, 10.1016/s0002-8703(03)00324-7
  20. Baumgartner R. W., Sidler C., Mosso M., Georgiadis D., Caplan L. R., Ischemic Lacunar Stroke in Patients With and Without Potential Mechanism Other Than Small-Artery Disease * Editorial Comment, 10.1161/01.str.0000058486.68044.3b
  21. Ohira T., Shahar E., Chambless L. E., Rosamond W. D., Mosley T. H., Folsom A. R., Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study, 10.1161/01.str.0000239694.19359.88
  22. Jackson C., Sudlow C., Are Lacunar Strokes Really Different?: A Systematic Review of Differences in Risk Factor Profiles Between Lacunar and Nonlacunar Infarcts, 10.1161/01.str.0000157949.34986.30
  23. ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic), 10.1161/circulationaha.106.174526
  24. Greenland P., Abrams J., Aurigemma G. P., Bond M. G., Clark L. T., Criqui M. H., Crouse J. R., Friedman L., Fuster V., Herrington D. M., Kuller L. H., Ridker P. M., Roberts W. C., Stanford W., Stone N., Swan H. J., Taubert K. A., Wexler L., Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Noninvasive Tests of Atherosclerotic Burden : Writing Group III, 10.1161/01.cir.101.1.e16
  25. Dormandy J, Semin Vasc Surg, 12, 96 (1999)
  26. Kannel William B, The Demographics of Claudication and the Aging of the American Population, 10.1177/1358863x9600100111
  27. Criqui M. H., Fronek A., Barrett-Connor E., Klauber M. R., Gabriel S., Goodman D., The prevalence of peripheral arterial disease in a defined population, 10.1161/01.cir.71.3.510
  28. Hiatt William R., Marshall Julie A., Baxter Judith, Sandoval Rodney, Hildebrandt William, Kahn Louise R., Hamman Richard F., Diagnostic methods for peripheral arterial disease in the san luis valley diabetes study, 10.1016/0895-4356(90)90164-k
  29. Murabito Joanne M., Evans Jane C., Larson Martin G., Nieto Kenneth, Levy Daniel, Wilson Peter W. F., The Ankle-Brachial Index in the Elderly and Risk of Stroke, Coronary Disease, and Death : The Framingham Study, 10.1001/archinte.163.16.1939
  30. Hirsch Alan T., Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care, 10.1001/jama.286.11.1317
  31. Sander D., Schulze-Horn C., Bickel H., Gnahn H., Bartels E., Conrad B., Combined Effects of Hemoglobin A1c and C-Reactive Protein on the Progression of Subclinical Carotid Atherosclerosis: The INVADE Study, 10.1161/01.str.0000199034.26345.bc
  32. Adams R. J., Coronary Risk Evaluation in Patients With Transient Ischemic Attack and Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association, 10.1161/
  33. Touze E, Arch Mal Coeur Vaiss, 98, 15 (2005)
  34. Steg Ph. Gabriel, Bhatt Deepak L., Wilson Peter W. F., D’Agostino Ralph, Ohman E. Magnus, Röther Joachim, Liau Chiau-Suong, Hirsch Alan T., Mas Jean-Louis, Ikeda Yasuo, Pencina Michael J., Goto Shinya, REACH Registry Investigators for the, One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis, 10.1001/jama.297.11.1197
  35. McKenna Matthew, Wolfson Sidney, Kuller Lewis, The ratio of ankle and arm arterial pressure as an independent predictor of mortality, 10.1016/0021-9150(91)90014-t
  36. Doobay A. V., Sensitivity and Specificity of the Ankle-Brachial Index to Predict Future Cardiovascular Outcomes: A Systematic Review, 10.1161/01.atv.0000168911.78624.b7
  37. Sikkink Cornells JJM, van Asten Willem NJC, van ‘t Hof Martin A, van Langen Herman, van der Vliet J Adam, Decreased Ankle/Brachial Indices in Relation to Morbidity and Mortality in Patients with Peripheral Arterial Disease, 10.1177/1358863x9700200302
  38. Rothwell PM, Warlow CP, Prediction of benefit from carotid endar terectomy in individual patients: a risk-modelling study, 10.1016/s0140-6736(98)11415-0
  39. Diener Hans-Christoph, Ringleb Peter A, Savi Pierre, Clopidogrel for the secondary prevention of stroke, 10.1517/14656566.6.5.755
  40. Hankey Graeme J., Long-Term Outcome after Ischaemic Stroke/Transient Ischaemic Attack, 10.1159/000069936
  41. , Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology, 10.1093/eurheartj/ehl001
  42. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008, 10.1159/000131083
  43. Di Pasquale G., Pinelli G., Grazi P., Andreoli A., Corbelli C., Manini G. L., Urbinati S., Carini G. C., Incidence of silent myocardial ischaemia in patients with cerebral ischaemia, 10.1093/eurheartj/9.suppl_n.104
  44. de Roos A, Kroft L J M, Bax J J, Lamb H J, Geleijns J, Cardiac applications of multislice computed tomography, 10.1259/bjr/67045628
  45. Diehm Curt, Schuster Alexander, Allenberg Jens R., Darius Harald, Haberl Roman, Lange Stefan, Pittrow David, von Stritzky Berndt, Tepohl Gerhart, Trampisch Hans-Joachim, High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study, 10.1016/s0021-9150(03)00204-1
  46. Sander K, Nervenarzt, 131, 1853 (2006)
  47. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, 10.1016/s0140-6736(02)11911-8
  48. MACMAHON S, Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias, 10.1016/0140-6736(90)90878-9
  49. Ezzati Majid, Lopez Alan D, Rodgers Anthony, Vander Hoorn Stephen, Murray Christopher JL, Selected major risk factors and global and regional burden of disease, 10.1016/s0140-6736(02)11403-6
  50. Pistoia F, Cerebrovasc Dis, 21, 10 (2006)
  51. Boshuizen H. C., Lanti M., Menotti A., Moschandreas J., Tolonen H., Nissinen A., Nedeljkovic S., Kafatos A., Kromhout D., Effects of Past and Recent Blood Pressure and Cholesterol Level on Coronary Heart Disease and Stroke Mortality, Accounting for Measurement Error, 10.1093/aje/kwk021
  52. Menotti Alessandro, Lanti Mariapaola, Kromhout Daan, Kafatos Anthony, Nedeljkovic Srecko, Nissinen Aulikki, Short and long term association of a single serum cholesterol measurement in middle-aged men in prediction of fatal coronary and other cardiovascular events: A cross-cultural comparison through Europe, 10.1007/s10654-005-7918-8
  53. Sander K., Schulze Horn C., Briesenick C., Sander D., High-Sensitivity C-Reactive Protein Is Independently Associated With Early Carotid Artery Progression in Women But Not in Men: The INVADE Study, 10.1161/strokeaha.106.481531
  54. Desbien Angela M., Chonchol Michel, Gnahn Hannes, Sander Dirk, Kidney Function and Progression of Carotid Intima-Media Thickness in a Community Study, 10.1053/j.ajkd.2007.11.026
  55. Graham Ian M., Plasma Homocysteine as a Risk Factor for Vascular Disease : The European Concerted Action Project, 10.1001/jama.1997.03540460039030
  56. Hoogeveen E. K., Kostense P. J., Beks P. J., Mackaay A. J. C., Jakobs C., Bouter L. M., Heine R. J., Stehouwer C. D. A., Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non Insulin-Dependent Diabetes Mellitus : A Population-Based Study, 10.1161/01.atv.18.1.133
  57. Robinson K., Arheart K., Refsum H., Brattstrom L., Boers G., Ueland P., Rubba P., Palma-Reis R., Meleady R., Daly L., Witteman J., Graham I., Low Circulating Folate and Vitamin B6 Concentrations : Risk Factors for Stroke, Peripheral Vascular Disease, and Coronary Artery Disease, 10.1161/01.cir.97.5.437
  58. Boushey Carol J., A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease : Probable Benefits of Increasing Folic Acid Intakes, 10.1001/jama.1995.03530130055028
  59. Mui K.-W., Incidental Renal Artery Stenosis Is an Independent Predictor of Mortality in Patients with Peripheral Vascular Disease, 10.1681/asn.2005080827
  60. Wright Julian R., Shurrab Ala'a E., Cheung Ching, Waldek Steven, O'Donoghue Donal J., Foley Robert N., Mamtora Hari, Kalra Philip A., A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease, 10.1053/ajkd.2002.33384
  61. Greenfield Sheldon, Apolone Giovanni, McNeil Barbara J., Cleary Paul D., The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement : Comorbidity and Outcomes After Hip Replacement, 10.1097/00005650-199302000-00005
  62. Röther J, Stroke, 38, 531 (2007)
  63. Terent A., Cerebrovascular Mortality 10 Years After Stroke: A Population-Based Study, 10.1161/01.str.0000129333.87858.4f
  64. Bronnum-Hansen H., Davidsen M., Thorvaldsen P., Long-Term Survival and Causes of Death After Stroke, 10.1161/hs0901.094253
  65. Vernino S., Brown R. D., Sejvar J. J., Sicks J. D., Petty G. W., O'Fallon W. M., Cause-Specific Mortality After First Cerebral Infarction: A Population-Based Study, 10.1161/01.str.0000080534.98416.a0
  66. Leys Didier, Kwiecinski Hubert, Bogousslavsky Julien, Bath Philip, Brainin Michael, Diener Hans-Christoph, Kaste Markku, Sivenius Juhani, Hennerici Michael G., Hacke Werner, Prevention, 10.1159/000074817
  67. Sacco R. L., Adams R., Albers G., Alberts M. J., Benavente O., Furie K., Goldstein L. B., Gorelick P., Halperin J., Harbaugh R., Johnston S. C., Katzan I., Kelly-Hayes M., Kenton E. J., Marks M., Schwamm L. H., Tomsick T., Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline., 10.1161/01.str.0000199147.30016.74
  68. Graham Ian, Atar Dan, Borch-Johnsen Knut, Boysen Gudrun, Burell Gunilla, Cifkova Renata, Dallongeville Jean, Backer Guy De, Ebrahim Shah, Gjelsvik Bjørn, Herrmann-Lingen Christoph, Hoes Arno, Humphries Steve, Knapton Mike, Perk Joep, Priori Silvia G., Pyorala Kalevi, Reiner Zeljko, Ruilope Luis, Sans-Menendez Susana, Op Reimer Wilma Scholte, Weissberg Peter, Wood David, Yarnell John, Zamorano Jose Luis, Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts), 10.1097/01.hjr.0000277984.31558.c4
  69. Mancia Giuseppe, De Backer Guy, Dominiczak Anna, Cifkova Renata, Fagard Robert, Germano Giuseppe, Grassi Guido, Heagerty Anthony M, Kjeldsen Sverre E, Laurent Stephane, Narkiewicz Krzysztof, Ruilope Luis, Rynkiewicz Andrzej, Schmieder Roland E, Boudier Harry AJ Struijker, Zanchetti Alberto, 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension : ESH-ESC Task Force on the Management of Arterial Hypertension, 10.1097/hjh.0b013e3282f0580f
  70. Smith S. C., AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute, 10.1161/circulationaha.106.174516
  71. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G.R., Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), 10.1016/j.ejvs.2006.09.024
  72. Wilcox R., Bousser M.-G., Betteridge D. J., Schernthaner G., Pirags V., Kupfer S., Dormandy J., , Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04), 10.1161/01.str.0000257974.06317.49
  73. Lincoff A. Michael, Wolski Kathy, Nicholls Stephen J., Nissen Steven E., Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus : A Meta-analysis of Randomized Trials, 10.1001/jama.298.10.1180
  74. High-Dose Atorvastatin after Stroke or Transient Ischemic Attack, 10.1056/nejmoa061894
  75. Olsen T. S., Christensen R. H. B., Kammersgaard L. P., Andersen K. K., Higher Total Serum Cholesterol Levels Are Associated With Less Severe Strokes and Lower All-Cause Mortality: Ten-Year Follow-Up of Ischemic Strokes in the Copenhagen Stroke Study, 10.1161/strokeaha.107.490292
  76. Diener H.C., Cunha L., Forbes C., Sivenius J., Smets P., Lowenthal A., European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke, 10.1016/s0022-510x(96)00308-5
  77. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial, 10.1016/s0140-6736(06)68734-5
  78. Sacco Ralph L., Sivenius Juhani, Diener Hans-Christoph, Efficacy of Aspirin Plus Extended-Release Dipyridamole in Preventing Recurrent Stroke in High-Risk Populations, 10.1001/archneur.62.3.403
  79. Van de WF, Eur Heart J, 24, 28 (2003)
  80. Bassand J.-P., Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm, 10.1093/eurheartj/ehm132
  81. , Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology, 10.1093/eurheartj/ehi138
  82. Diener Hans-Christoph, Bogousslavsky Julien, Brass Lawrence M, Cimminiello Claudio, Csiba Laszlo, Kaste Markku, Leys Didier, Matias-Guiu Jordi, Rupprecht Hans-Jürgen, Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial, 10.1016/s0140-6736(04)16721-4
  83. JANZON L., BERGQVIST D., BOBERG J., BOBERG M., ERIKSSON I., LINDGÄRDE F., PERSSON G., Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study, 10.1111/j.1365-2796.1990.tb00164.x
  84. Balsano F., Rizzon P., Violi F., Scrutinio D., Cimminiello C., Aguglia F., Pasotti C., Rudelli G., Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group, 10.1161/01.cir.82.1.17
  85. Coccheri S, Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study, 10.1053/euhj.2001.3033
  86. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C. J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., Hong Y., , Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, 10.1161/circulationaha.106.179918
  87. Hiatt William R., Medical Treatment of Peripheral Arterial Disease and Claudication, 10.1056/nejm200105243442108